Robert Bridge, MD
Otolaryngology · Phoenix, AZNPI 1700882990
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,515 of the $5,576 with a category attached, or 81.0%. 15 manufacturers reported payments, led by Stryker at 34.5% of the total. Reporting peaked in 2019 at $2,689 and has fallen 87.9% since, to $325 in 2025.
Across 147 payments — averaging $37.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Optinose US, Inc.$1K
- Sanofi$675
- Acclarent, Inc$390
- Intersect ENT, Inc.$367
- GSK$347
- plus $699 from 9 others
What the payments were for
- Travel & lodging$97918%
- Food & beverage$4,51581%
- Education$821%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 15 | $1,924 |
| Optinose US, Inc. | 54 | $1,173 |
| Sanofi | 30 | $675 |
| Acclarent, Inc | 6 | $390 |
| Intersect ENT, Inc. | 3 | $367 |
| GSK | 18 | $347 |
| Regeneron Healthcare Solutions, Inc. | 8 | $200 |
| Aerin Medical Inc. | 5 | $187 |
| Neurent Medical Limited | 2 | $91 |
| Sanofi-aventis U.S. LLC | 1 | $82 |
| Preceptis Medical, Inc. | 1 | $54 |
| Mimedx Group, Inc. | 1 | $23 |
| Arrinex, Inc. | 1 | $23 |
| Smith+Nephew | 1 | $22 |
| Boston Scientific | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENTELLUS - XPRESS ENT DILATION SYSTEM$1,226
- Xhance$354
- DUPIXENT$244
- TruDi Nav Cable$225
- SPIROX - LATERA$171
- VenSure$148
- PROPEL$144
- ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM$135
- CLARIFIX$118
How this compares
$5,576 in reported general payments places this provider in the 85th percentile of 150 otolaryngology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 129 | $2,249 |
| Ipratropium Bromide | 40 | $1,307 |
| Fluocinolone Acetonide Oil | 17 | $670 |
| Gabapentin | 40 | $323 |
| Fluticasone Propionate | 24 | $314 |
| Fluocinonide | 13 | $306 |
| Omeprazole | 34 | $288 |
| Clindamycin Hcl | 14 | $124 |
| Prednisone | 22 | $77 |
| Ondansetron OdtOndansetron | 11 | $73 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Phoenix
- Peter KaiserPhoenix$114K
- Farhan TaghizadehPhoenix$46K
- Shawn StevensPhoenix$33K
- Richard PearlsteinPhoenix$10K
- Devyani LalPhoenix$8K
- Christian PaquetPhoenix$8K
- Alyson KaplanPhoenix$6K
- Manikandan SugumaranPhoenix$6K
- Jeffrey TaffetPhoenix$6K
- Michael GutmanPhoenix$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.